HomeOrganizations › OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM

OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM

OH · Disease Research · EIN 311340154

0
Executives Disclosed
$88K
Annual Revenue
$334K
Total Assets

OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM has 0 executives with disclosed compensation. The sector average for Disease Research executives is $215K.


Executive Compensation

Name Title Peak Comp. Latest Comp. Years vs. Household
Email Alerts

Get notified about OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM

Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.